Ausgabe 11/2016
Inhalt (14 Artikel)
CD47: a potential immunotherapy target for eliminating cancer cells
F. Kong, F. Gao, H. Li, H. Liu, Y. Zhang, R. Zheng, Y. Zhang, J. Chen, X. Li, G. Liu, Y. Jia
Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs
C. N. Kent, I. K. Guttilla Reed
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-López, E. M. Corrales-García
Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
P. García-Alfonso, J. Feliú, R. García-Carbonero, C. Grávalos, C. Guillén-Ponce, J. Sastre, J. García-Foncillas
Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer
F. Selcukbiricik, M. Kanbay, Y. Solak, A. Bilici, M. Kanıtez, E. Balık, N. M. Mandel
Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study
J. Boceta, A. De la Torre, D. Samper, M. Farto, R. Sánchez-de la Rosa
The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the “Hôpital Tenon” score revisited. A two-institution study
I. Barco, A. García-Fernández, C. Chabrera, M. Fraile, E. Vallejo, J. M. Lain, J. Deu, S. González, C. González, E. Veloso, J. Torres, M. Torras, L. Cirera, A. Pessarrodona, N. Giménez, M. García-Font
Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II–III esophageal carcinoma
M. Caro, A. Font, S. Comas, M. Viciano, J. Remon, P. Céliz, J. Robles, E. Musulén, M. J. Sendrós, E. Mesalles, J. A. Jiménez, J. Boix, A. Arellano, J. Fernández-Llamazares
Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location
R. Seijas-Tamayo, J. Fernández-Mateos, J. C. Adansa Klain, R. Mesía, M. Pastor Borgoñón, E. Pérez-Ruiz, S. Vázquez Fernández, C. Salvador Coloma, A. Rueda Domínguez, M. Taberna, J. Martínez-Trufero, T. Bonfill Abella, S. Vázquez Estévez, M. Pollán, E. del Barco Morillo, J. J. Cruz-Hernández
Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
Y. Zhao, W. You, J. Zheng, Y. Chi, W. Tang, R. Du
Extreme liver surgery as treatment of liver tumors involving the hepatocaval confluence
C. Codony, S. López-Ben, M. Albiol, L. Falgueras, E. Castro, A. Codina-Barreras, M. Casellas, J. Gil, A. Codina-Cazador, J. Figueras
Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab
R. Montal, M. Oliva, M. Taberna, L. De Avila, A. Rovira, M. Cos, M. Mañós, V. Navarro, J. Nogués, A. Lozano, L. Rodríguez, E. Vilajosana, S. Vázquez, R. Mesia
Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
A. M. Arance, A. Berrocal, J. A. Lopez-Martin, L. de la Cruz-Merino, V. Soriano, S. Martín Algarra, L. Alonso, P. Cerezuela, B. La Orden, E. Espinosa
Stereotactic body radiotherapy in non-operable lung cancer patients
R. E. Vadalà, A. Santacaterina, A. Sindoni, A. Platania, A. Arcudi, G. Ferini, M. M. Mazzei, D. Marletta, C. Rifatto, E. V. I. Risoleti, C. Severo, A. Pontoriero, G. Iatì, S. Pergolizzi